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1. Background
The unique potential of the mesenchymal stem
cells (MSCs) to modulate immune responses prompts
their promising application in the regenerative medi-
cine and tissue engineering. The multilineage differen-
tiation potential of the human adipose-derived mes-
enchymal stem cells (hADSCs) together with the less
invasive accessibility makes them a proper candidate
for cell therapy (1, 2). Study on the application of sev-
eral artificial extracellular matrices (ECMs) with dif-
ferent composites and their three-dimensional (3D)
distribution patterns are considered as an interesting
topic in attempt to improve their therapeutic capabili-
ties (3). The exposed microenvironment of the 3D cul-
tures that mimics in vivo conditions provides more
effective interactions between cells and their microen-
vironment (4). Regarding the fact that the expansion
and differentiation of adult stem cells depends on the
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Background: Expansion and differentiation of stem cells relies on the soluble materials as well as the physical conditions
of their microenvironment. Several methods have been studied in attempt to enhance the growth and differentiation rates
of different adult stem cells extracted from different sources. 
Objectives: The purpose was to improve the three-dimensional (3D) culture condition of the semi-permeable polymeric
beads for encapsulation of the human adipose-derived mesenchymal stem cells (hADSCs) by modifying the ratio of the
alginate-gelatin composition. 
Materials and Methods: Following isolation and characterization of hADSCs by flow cytometry and their functional dif-
ferentiation, encapsulation in the alginate and alginate/gelatin compositions were performed. Moreover, the stability,
swelling, size frequency, growth kinetics, and cytotoxicity of the beads were measured to meet proper condition in the
designed experimental and control culture conditions. Finally, the growth rates of the cells in different experimental groups
and control were measured and analyzed statistically. 
Results: Viability decreased in 2 and 3 percent alginate once compared to 1% alginate in beads (p≤0.05). Moreover
swelling of the beads in the alginate/gelatin compositions (50:50 and 70:30) were higher than the pure alginate beads (p≤
0.05). Finally, the cell growth rate in alginate/gelatin (50:50) beads was significantly higher than alginate and alginate/gel-
atin (70:30) beads (p≤0.05). 
Conclusions: These findings suggested for the first time that the composite of alginate/gelatin beads with the ratio of 50:50
might provide a suitable culture condition for the encapsulation and in vitro expansion of the hADSCs. 
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different signals provided by their microenvironment,
improving proliferation and differentiation of MSCs
has been the topic of interest (5-7). In this regard, the
applications of the artificial scaffolds and encapsula-
tion of the cells in semi-permeable polymeric materi-
als appeared to enhance cell growth, differentiation,
and protein production (8, 9). Moreover, biocompati-
ble polymers such as alginate, chitosan, and collagen
together with synthetic polymers such as poly (ethyl-
ene glycol) (PEG), poly (lactic acid) (PLL), poly (ε-
caprolactone), and gelatin, as a natural polymer had
been implemented frequently (10-14). Among these
polymers, gelatin has some advantages when prepar-
ing artificial ECMs (15, 16). It is a water soluble
biopolymer with a high biodegradation rate. Next to
gelatin, sodium alginate seems to be a proper polymer.
Due to its composition, it can bind to other biomateri-
als such as bioglass, hydroxyapatite, chitosan, and col-
lagen to produce popular matrices in human cell cul-
tures (17-19). Modifications of alginate concentration
in 3D structure system have shown to enhance insulin
production in insulin-producing cells obtained from
embryonic stem cells (20). The alginate microcapsules
cross-linked with Ca2+ and Ba2+ reported to provide
suitable pore size to improve cell viability and protein
secretion (21). However, no study was reported to
compare different composites of alginate/gelatine
hydrogels in order to improve the growth rate of the
hMSCs. 
2. Objectives
Based on the potential therapeutic application of
hADSCs and alginate beads, the purpose of the current
study was to improve the growth rate of hADSCs in
the 3D culture condition by the addition of different
ratio of the gelatin to the alginate biopolymer beads. 
3. Materials and Methods 
3.1. Materials and Stock Preparation 
Sodium alginate (Mw: 100,000-200,000 g.mol-1,
G-Content: 65-70%) and gelatin (type A from porcine
skin, 300 Bloom), indomethacin, dexamethasone,
insulin, ascorbic acid, glycerol phosphate, and Isobutyl
methyl xanthine were purchased from Sigma-Aldrich
(St. Louis, MO, USA). Dulbecco’s modified Eagle’s
medium (DMEM, Invitrogen, CA, USA), Fetal Bovine
Serum (FBS, Invitrogen, CA, USA), and trypsin were
purchased from GIBCO Invitrogen (Invitrogen, CA,
USA). Fluorescent isothiocyanate (FITC)-conjugated
mouse anti-human CD90, CD45 and Phycoerythrin
(PE)-conjugated CD44, CD73, CD105, and CD34 pur-
chased from Abcam, Cambridge, MA, USA). Lactate
dehydrogenase (LDH) activity assay kit was from
Greiner Diagnostic GmbH, Bahlingen, Germany.
Glucose and lactate assay kits were from Greiner
Diagnostic GmbH, Bahlingen, Germany. Other chem-
icals were purchased from MERCK Co. (Germany). 
Alginate and gelatin stocks were prepared in
DMEM. Gelatin (4%) and alginate (4%) were dis-
solved in 100 mL distilled water, separately. After ster-
ilizing at 80°C, DMEM (2X) was added to obtain final
concentration of 2% (w/v). Different ratios were taken
from the stock solutions to prepare alginate:gelatin
compositions as shown in Table 1. 
3.2. Isolation, Culture and Characterization of
HADSCs 
Human adipose tissues were obtained from
abdominoplasty procedures. Written informed con-
sents were obtained from all donors and the Local
Ethical Committee approved the investigational use of
the tissues. Tissues were washed three times with
phosphate-buffered saline (PBS) and digested with
0.1% wild collagenase (Sigma, St Louis, MO) for 50
min at 37ºC. Enzyme activity was neutralized with
FBS. The neutralized cell suspensions were cen-
trifuged at 1000 rpm for 5 min. Floating adipocytes
were removed and the pellets of mesenchymal stem
cells were filtered through the cell strainer before plat-
ing (pore size 150 μm, Millipore, USA). The cells
were cultured in DMEM containing 100 U.mL-1 of
penicillin/streptomycin and 10% FBS at 37°C in the
atmosphere containing 5% CO2. The medium was
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Compositions Stock solution % (w/v) Proportions % Final concentration (w/v)
Alginate/Gelatin
Alginate/Gelatin
Alginate/Gelatin
Alginate/Gelatin
1
2:2
2:2
2:2
100:0
30:70
50:50
70:30
1
0.6:1.4
1:1
1.4:0.6
Table 1. Composition of alginate/gelatin suspensions and main characteristics of final con-
centrations
replenished after 72 h culture. When cells reached 70-
80% confluence, cultures were harvested with 0.25%
trypsin-EDTA solution, resuspended in growth medi-
um, and subcultured. 
To characterize the obtained cells, cells at the third
passage were harvested, resuspended in PBS, and cen-
trifuged. About 2×105 cells were centrifuged at 300 ×g
for 5 min at 22°C. The pellet was suspended in PBS
and incubated for 45 min on ice with appropriate anti-
bodies including fluorescent isothiocyanate (FITC)-
conjugated mouse anti-human CD90, CD45 and
Phycoerythrin (PE)-conjugated CD44, CD73, CD105,
and CD34. The labeled cells were washed with PBS
and analyzed using a FACS-Calibur (Becton
Dickinson, USA). An isotype control with FITC or PE-
labeled was included in each experiment and specific
staining was measured from the cross point of the iso-
type with the specific antibody graph. Histograms
were prepared with Win MDI 2.8 software (Scripps
Institute, La Jolla, CA, USA). For adipogenic differen-
tiation, the cells in the third passage were cultured for
2 weeks in the defined adipogenic medium, containing
growth medium supplemented with 200 μM
indomethacin, 1 μM dexamethasone, 1.7 μM insulin,
and 500 μM isobutyle methyl zantin. In negative con-
trol, cells in the third passage were cultured in growth
medium for 2 weeks and stained by Oil red. For
osteogenic differentiation, the cells in the third passage
were cultured for 2 weeks in the defined osteogenic
medium, containing growth medium supplemented
with 10 μM dexamethasone, 10 μM glycerol phos-
phate, and 0.05 g.L-1 ascorbic acid. In negative con-
trol, cells in the third passage were cultured in growth
medium for 2 weeks and stained by Alizarin red.
3.3. Beads Swelling and Stability Tests 
The stability of the samples was assessed in 0.9%
(w/v) NaCl solution. Beads (30) were incubated in
NaCl solution and fractured beads were counted every
three days. The fracture frequency was calculated
using the following formula:
The beads swelling were calculated based on bead
weight increment in NaCl solution. Briefly, freshly
prepared beads weighed and placed in a glass vial con-
taining 100 mL of NaCl solution and incubated at
37ºC followed by shaking at 110 rpm for 5 h. The wet
weight of the swollen beads was determined by blot-
ting with filter paper to remove excess moisture adher-
ing to the surface that immediately followed by weigh-
ing on an electronic balance. At least 30 beads were
measured in each experimental group. The beads
swelling were calculated from the following formula,
where Wi was the initial weight of the beads and Wt
was the weight of the swollen beads: 
3.4. Preparation of Gel Beads Containing Gelatin and
Alginate 
A confluent monolayer of adherent hADSCs was
removed following trypsin-EDTA incubation. The cell
suspensions were centrifuged at 1000 rpm for 5 min at
4°C. The cell pellet re-suspended in alginate:gelatin
solutions. All groups were cultured at the same cell
density of 5×105 cells.mL-1 of alginate. The beads
were generated by extruding the cell: alginate/gelatin
mixture from a plastic syringe via 30 G needle into a
20 mL bath of CaCl2 (100 mM), containing 145 mM
NaCl, and 10 mM HEPES. Formed beads were main-
tained in CaCl2 bath for 10 min at 22°C. Generated
beads washed with hank’s buffer three times. The algi-
nate beads were cultured in bacterial petri dishes in
order to minimize the adhesion of cells on the excess
surface. In another group, the cell culture flasks were
used for 2D culture of hADSCs. All groups were cul-
tured at the same conditions of inoculums and volume
of basal medium. 
3.5. Cell Analysis Following Encapsulation 
For analysis of the viable cells following prolifera-
tion and cell growth, the supernatant was removed
from the bacterial plates and beads were washed with
Hank’s buffer. The sodium citrate solution (100 mM in
PBS) was used for decrosslinking beads at exposure
time of 10 min.  The cell suspension was centrifuged
at 80 ×g for 5 min and the pellet used for cell count and
viability test by trypan blue method. 
Glucose and lactate concentrations were measured
by the glucose and lactate assay kits, as explained by
the manufacturer. The cytotoxicity assay was meas-
ured by lactate dehydrogenase (LDH) activity assay kit
(Greiner Diagnostic GmbH, Bahlingen, Germany),
according to the guidelines of the manufacturer. 
3.6. Statistical Analysis 
All experiments were carried out in triplicate and
the results were reported as the mean values. The stan-
dard deviation was calculated by Microsoft Excel soft-
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ware. One-way ANOVA was used to compare the
means (p≤0.05). All statistical calculations were car-
ried out using SPSS software (version 16 from
Softonic). 
4. Results 
4.1. Beads Stability and Swelling 
Following 9 days of incubation, the stability of
beads was decreased by 70% in alginate/gelatin
(50:50) (p≤0.05) compared to that of alginate beads
(Figure 1). However, no significant decrease in stabil-
ity was observed in alginate/gelatin beads (70:30)
(p≤0.05) when compared to that of the alginate.
Alginate beads with the ratio of 30:70 were not stable
( Figure 1 ). 
Beads stability and swelling rate relationship was
established. Swelling of the beads’ increased by the
addition of the gelatin to the alginate beads. The
swelling of the alginate/gelatin (50:50) beads were
57% more than that of the alginate beads, whereas no
significant difference were observed between algi-
nate/gelatin (70:30) swelling in comparison with algi-
nate beads (p≤0.05). Thus, it might be concluded that
the size of the beads was larger in alginate/gelatin
beads compared to that of the alginate beads.
Furthermore, these results demonstrated that the
increase in the swelling could adversely affect the sta-
bility. The data obtained from cell recovery measure-
ments of dissolved beads as shown in (Table 1), indi-
cated that the addition of the gelatin to the alginate
solution had no considerable effect on the cellular loss
(Table 1).
4.2. Cell Characterization, Viability and Proliferation
Flow cytometry is routinely used for the character-
ization of isolated cells. The results of immunopheno-
typing profile indicated that the cells were positive for
CD90 (96.30%), CD 105 (96.08%), and CD73
(90.97%), which together were considered as markers
for human MSCs. The cells were negative for
hematopoitic lineage and the human leukocyte mark-
ers including CD45 (0.35%), CD31 (0.26%), CD34
(0.18%) (Figure 2A). Furthermore, the mesodermal
differentiation results from Oil red (Figure 2, panel B,
right side) and alizarin-red  (Figure 2, panel B left side)
stains confirmed the presence of lipid droplets and cal-
cium deposits in the adipogenic and osteogenic
induced differentiated cells, respectively (Figure 2,
panel B). These pieces of evidence together with
fibroblastic morphology and clonogenic capacity of
the cells (data not shown) allowed us to conclude that
the cultivated cells had the basic properties of human
ADSCs (Figure 2). 
The viability of hADSCs in alginate beads were
determined by trypan blue method. Comparing to 1%
alginate beads, the cells’ viabilities were decreased by
44% and 53% (p≤0.05) in groups cultured in 2% and
3% alginate beads, respectively (Figure 3). Viability of
the cells in the alginate/gelatin compositions (50:50
and 70:30) was higher than 2% and 3% alginate beads
(Figure 3). 
The state of cellular viability was measured by
direct and indirect methods. Glucose consumption as
well as the formation of by-products considered as
indirect methods to evaluate cells viabilityGlucose and
lactate concentrations were measured in 3D culture of
hADSCs to assess whether the gelatin had negative
effect on the proliferation and viability of hADSCs or
not. Glucose consumption increased from 131 mg.L-1
in alginate/gelatin beads (50:50) to 268 mg.L-1 in algi-
nate beads, as the control (Figure 4). 
Interestingly, the yield of lactate per glucose
(YLac/Glc), as an indicator of proper cell respiration,
had no significant difference between the alginate
beads and alginate/gelatin (70:30) beads cultures
(p≤0.05). The alginate/gelatin (50:50) prepared suit-
able respiration condition due to the decrease in the
yield of lactate per glucose (YLac/Glc) (Table 2). The
hADSCs specific growth rate was only calculated in
alginate/gelatin beads because of lower proliferation in
alginate and alginate/gelatin (70:30) beads. The appli-
cation of lactate dehydrogenase (LDH) release for the
evaluation of death and growth of human cells in 3D
culture was regarded as an indirect method of cell via-
Rezaei S. et al.
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Figure 1. The influence of alginate/gelatin compositions on stabil-
ity of the beads during 3, 6, and 9 days of incubation time
bility. Here, the LDH activity showed that there was no
substantial difference between three samples (Table 2). 
5. Discussion 
For the clinical practice in all trials for different cell
therapies, some challenges are to overcome in the field
of cell biology as well as the material science and
encapsulation technology. On the biological side, a
crucial need for suitable source of proper cells is
inevitable. Stem cells are proper functional cell
Iran J Biotech. 2016;14(1):e1185
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Hydrogel (μ) (1/h) YLac/Glc
(mg.mg-1)
LDH activity
(U.L-1)
Swelling (%) Beads size
(mm)
Recovery (%)
Alginate
Alginate/Gelatin (50:50)
Alginate/Gelatin (70:30)
-----
0.009± 0.005
---
0.99 ± 0.12
0.83 ± 0.18
0.87 ± 0.1
87 ± 3
80± 5
85 ± 5
57± 5
85± 4
69± 2
2.2±0.1
3.7±0.2
3.2±0.15
88± 2
92± 5
91± 4
Table 2. Calculated parameters in different compositions of the alginate/gelatin beads
* *
LDH: Lactate dehydrogenase 
YLac/Glc: Lactate/Glucose
μ: Specific growth rate (1/h)
*
Figure 2. A: Immunophenotyping of isolated hADSCs. The isolated hADSCs in the third passage were
negative for hematopoietic, and leukocyte cell markers (CD31, CD34, CD45) and positive for the mes-
enchymal cell markers (CD73, CD90, CD105). B: Osteogenic and adipogenic differentiation of isolated
hADSCs. Osteogenic differentiation was positive for alizarin red staining (left) and the adipose droplet
in differentiated cells were positive after staining with oil red (right). Scale bars 10 μm
sources as opposed to differentiated mature cells.
Because of ethical reasons and a lower risk of virus
transfer, patient’s own cells, especially MSCs are pre-
ferred. However, similar to many primary cells, the
characteristics of MSCs changed with  increasing  pop-
ulation doublings. Despite traditional cell culture
processes in which a secreted protein or products are
desired, the purpose of stem cell cultivation is to
expand stem cells and sustain their multipotency,
meaning that the functional cell itself is the final prod-
uct. To date, encapsulation of stem cells in semi-per-
meable polymeric materials has implemented to
enhance cell growth and sustain their multipotency.
Moreover, considering the fact that the alginate micro-
capsule walls protect the cells from the immunological
reactions, cell therapy by microencapsulated cells can
facilitate its medical application (22). MSCs have the
ability to modulate oxidative stress, and secrete vari-
ous cytokines and growth factors that have
immunomodulatory, angiogenic, anti-inflammatory
and anti-apoptotic effects. ADSCs are studied as an
alternative to bone marrow-derived multipotent stro-
mal cells (BM-MSCs). ADSCs in comparison with
BM-MSCs can be isolated more easily; considerably
larger amounts of ADSCs can be obtained, in less inva-
sive and safer fashion. Furthermore, the immunomod-
ulatory capacities of ADSCs and AT-MSCs are similar
however differences in cytokine secretion cause
ADSCs to have more potent immunomodulatory
effects than BM-MSCs (23). Therefore, they are an
attractive cell source for clinical cell therapy. Another
challenge in this regard is the formation of uniform
capsules with excellent repeatability and reproducibil-
ity. In general, it seems to be a problem that cells
agglutinate during encapsulation so that empty beads
are produced. One prospect is to distinguish between
empty and filled capsules. Moreover, many approach-
es need a defined stability of the cell capsules, which
has to be controlled by the material properties. Up to
now, it is not possible to create materials with such
degradation behaviors. 
Alginate is a polysaccharide, which has a frequent
medical application. The matrix formed by sodium
alginate is a popular technique in cell encapsulation
(10). Many parameters have direct effect on alginate
beads preparation in order to meet optimum cell
growth conditions such as alginate concentration,
beads size, and initial cell density. Considering that
alginate is a negatively charged polysaccharide, the
cells do not desire to adhere to the alginate easily.
Thus, mixing alginate biopolymer with the ECM asso-
ciated biopolymers could improve the cell adhesion
and proliferation. Gelatin is a water soluble biopoly-
mer with the high biodegradation rate. Consequently,
blending the alginate biopolymer with gelatin could
improve the cell proliferation in the generated beads.
Rezaei S. et al.
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Figure 4. Time-course profile of A: glucose consumption, B: lac-
tate formation in different compositions of alginate/gelatin beads
and alginate beads as control
Figure 3. The hADSCs viability in alginate/gelatin composition in
comparison with alginate beads considered as the control
Increasing in the stability of the beads could be due to
the increase of the alginate concentration in the com-
position. On the other hand, high levels of gelatin con-
centration diminished the beads stability. The algi-
nate/gelatin (30:70) had lower stability in comparison
with the beads with the alginate/gelatin ratio of 70:30.
Calcium ions as crosslinking agent bind to carboxyl
groups of alginates, stabilizing bead structure.
Addition of gelatin could disturb this crosslinking
process. Although the higher level of alginate concen-
tration increases the stability of the beads, the high
level of alginate concentration acts as a barrier to nutri-
ent transfer into the beads and release of toxic by-prod-
ucts from the beads. Consistently, the hADSCs cell
viability was reduced in 2% and 3% (w/v) alginate
solutions compared to that of the 1% alginate solution.
Taken together, the main purpose of the current
study was to introduce a proper encapsulation method
using hydrogels composed of the alginate and gelatin
to produce biocompatible beads in order to improve
the expansion of the hADSCs for further transplanta-
tion and therapeutic applications in the regenerative
medicine. While alginate has several advantages for
preparing the artificial ECM, gelatin as a natural poly-
mer has a promising application in medicine. 
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